Bretylium or 6‐OHDA‐resistant, action potential‐evoked Ca 2+ transients in varicosities of the mouse vas deferens

Action potential‐evoked calcium transients in varicosities in mouse vas deferens were monitored using laser scanning confocal microscopy. Their significance was examined by comparison with excitatory junction potentials (EJPs) and neurogenic contractions, both indirect measurements of transmitter re...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2009-02, Vol.135 (8), p.1845-1850
Main Authors: Jackson, V Margaret, Cunnane, Tom C
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Action potential‐evoked calcium transients in varicosities in mouse vas deferens were monitored using laser scanning confocal microscopy. Their significance was examined by comparison with excitatory junction potentials (EJPs) and neurogenic contractions, both indirect measurements of transmitter release. Bretylium abolished EJPs, as well as the ATP and NA‐mediated phases of contraction. However, bretylium revealed a prominent late component of contraction that was atropine‐sensitive. Bretylium abolished calcium transients in 21%, enhanced in 16% and had no effect in 63% of varicosities examined. Pre‐treatment with 6‐OHDA reduced NA levels to below detectable levels but many strings of varicosities still responded to nerve impulses with ‘normal’ calcium transients. Varicosities in which calcium transients were abolished by these agents were sympathetic. The identity of those varicosities in which calcium transients were resistant to bretylium (sympathetic but no uptake‐1 sites, parasympathetic, sensory) remains to be established. British Journal of Pharmacology (2002) 135 , 1845–1850; doi: 10.1038/sj.bjp.0704677
ISSN:0007-1188
1476-5381
DOI:10.1038/sj.bjp.0704677